Centene Corporation: updates and filings

CNCNYSEHealthcare · Hospital & Medical Service Plans

Price

$67.73

November 18, 2026Market cap $33.3B

What Ploutos Investor adds for Centene

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from 2009
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • Profit over the last twelve months is well above what the business itself earned, because it includes large gains outside the business, such as on investments or from selling a business. The P/E is lower than the business alone would give.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 71 daysAround Jan 28, 2027 · for Q4 2026

last Oct 27, 2026next Jan 28, 2027

An estimate from when it has reported before, which has been regular. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Feb 17, 2026 latest annualOct 27, 2026 latest quarterly
  • Oct 27, 2026Results of operations
    Form8-K
  • Oct 27, 2026Quarterly reportfor the period to Sep 30, 2026
    Form10-Q
  • Oct 8, 2026Other material events
    Form8-K
  • Sep 16, 2026Regulation FD disclosure
    Form8-K
  • Aug 17, 2026Officer or director change, Regulation FD disclosure
    Form8-K
  • Jul 29, 2026Other material events
    Form8-K
  • Jul 28, 2026Results of operations, officer or director change, Regulation FD disclosure
    Form8-K
  • Jul 28, 2026Quarterly reportfor the period to Jun 30, 2026
    Form10-Q
  • Jun 22, 2026Officer or director change, Regulation FD disclosure
    Form8-K
  • May 15, 2026Officer or director change, shareholder vote
    Form8-K
  • Apr 29, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Apr 28, 2026Results of operations
    Form8-K
  • Apr 28, 2026Quarterly reportfor the period to Mar 31, 2026
    Form10-Q
  • Mar 26, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Mar 26, 2026Additional annual meeting material
    FormDEFA14A
  • Mar 26, 2026Annual meeting proxy statement
    FormDEF 14A
  • Mar 24, 2026Officer or director change
    Form8-K
  • Mar 10, 2026Regulation FD disclosure, other material events
    Form8-K
  • Feb 23, 2026Regulation FD disclosure
    Form8-K
  • Feb 17, 2026Annual reportfor the period to Dec 31, 2025
    Form10-K
  • Feb 13, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Feb 6, 2026Results of operations
    Form8-K
  • Nov 10, 2025Regulation FD disclosure
    Form8-K
  • Nov 5, 2025Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Nov 4, 2025Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC since Oct 9, 2001: every report, 8-K, meeting and letter. Of its other filings (940 in all), the newest. Of its note and share prospectuses (424B, FWP), the newest 40 of 49.

The full analysis

What do Centene's filings show?

The filings are where every one of Centene's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.